Cone-beam computed tomography (CBCT) image-quality improvement using a denoising diffusion probabilistic model conditioned by pseudo-CBCT of pelvic regions.
Authors
Affiliations (6)
Affiliations (6)
- Graduate School of Science and Engineering, Yamagata University, Yonezawa, 992-8510, Japan. [email protected].
- Department of Radiology, Yamagata University Hospital, Yamagata, 990-9585, Japan. [email protected].
- Department of Heavy Particle Medical Science, Graduate School of Medical Science, Yamagata University, Yamagata, 990-9585, Japan.
- Department of Radiology, Division of Diagnostic Radiology, Faculty of Medicine, Yamagata University, Yamagata, 990-9585, Japan.
- Department of Radiology, Yamagata University Hospital, Yamagata, 990-9585, Japan.
- Graduate School of Science and Engineering, Yamagata University, Yonezawa, 992-8510, Japan.
Abstract
Cone-beam computed tomography (CBCT) is widely used in radiotherapy to image patient configuration before treatment but its image quality is lower than planning CT due to scattering, motion, and reconstruction methods. This reduces the accuracy of Hounsfield units (HU) and limits its use in adaptive radiation therapy (ART). However, synthetic CT (sCT) generation using deep learning methods for CBCT intensity correction faces challenges due to deformation. To address these issues, we propose enhancing CBCT quality using a conditional denoising diffusion probability model (CDDPM), which is trained on pseudo-CBCT created by adding pseudo-scatter to planning CT. The CDDPM transforms CBCT into high-quality sCT, improving HU accuracy while preserving anatomical configuration. The performance evaluation of the proposed sCT showed a reduction in mean absolute error (MAE) from 81.19 HU for CBCT to 24.89 HU for the sCT. Peak signal-to-noise ratio (PSNR) improved from 31.20 dB for CBCT to 33.81 dB for the sCT. The Dice and Jaccard coefficients between CBCT and sCT for the colon, prostate, and bladder ranged from 0.69 to 0.91. When compared to other deep learning models, the proposed sCT outperformed them in terms of accuracy and anatomical preservation. The dosimetry analysis for prostate cancer revealed a dose error of over 10% with CBCT but nearly 0% with the sCT. Gamma pass rates for the proposed sCT exceeded 90% for all dose criteria, indicating high agreement with CT-based dose distributions. These results show that the proposed sCT improves image quality, dosimetry accuracy, and treatment planning, advancing ART for pelvic cancer.